Multicenter clinical experience of real life Dalbavancin use in gram-positive infections

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
S WunschI Zollner-Schwetz

Abstract

Dalbavancin, a lipoglycopeptide with prolonged half-life approved for the treatment of acute bacterial skin and soft tissue infections, can be used for the treatment of infections caused by gram-positive bacteria requiring long term treatment such as endocarditis, prosthetic joint infections (PJI) or osteomyelitis. Clinical data are limited in these settings. To evaluate indications, safety, tolerability and long-term outcomes of dalbavancin-treated patients. Patients and methods Our multicenter, retrospective study includes patients who received dalbavancin in Austria from September 2016 to March 2018. 90-day outcomes and tolerability were determined. A total of 101 patients were included in 3 centers (57% male, median age 65 years). The treated infections were PJI (31%), osteomyelitis (29%), endocarditis (25%) and acute bacterial skin and soft tissue infections (12%). Concomitant use of other antimicrobial substances was common (63%). The mean total cumulative dose of dalbavancin was 3,357mg (±2,283mg). Clinical success rate was 89%. Side effects occurred in 3/101 patients. In this real-life study dalbavancin was primarily used in off-label indications for treatment of PJI, osteomyelitis and endocarditis. Success rate was hig...Continue Reading

Citations

Jan 18, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Monica V Mahoney, Simi Padival
Jun 6, 2020·The International Journal of Lower Extremity Wounds·Vasilios PetrakisNikolaos Papanas
May 28, 2020·The Journal of Antimicrobial Chemotherapy·Thamer A Almangour, Abdullah A Alhifany
Dec 24, 2019·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·David P Serota, Theresa Vettese
Oct 7, 2020·European Journal of Hospital Pharmacy. Science and Practice·Maria Arrieta-LoiteguiJose Miguel Ferrari-Piquero
Oct 20, 2020·Journal of Chemotherapy·Emanuele Durante-MangoniRosa Zampino
Nov 20, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia GonzalezJianLi Niu
Jul 30, 2020·International Journal of Antimicrobial Agents·Emanuele Durante-MangoniNicola Coppola
Nov 24, 2020·International Journal of Antimicrobial Agents·Michael P VeveMahmoud A Shorman
Oct 23, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F Escrihuela-VidalO Murillo
Jan 7, 2021·Current Opinion in Infectious Diseases·Matteo BassettiDaniele R Giacobbe
Mar 9, 2021·Expert Review of Anti-infective Therapy·Massimo AndreoniPierluigi Viale
Dec 7, 2020·Journal of Global Antimicrobial Resistance·Yuhang WangYun Cai
Aug 13, 2020·Infectious Disease Clinics of North America·David P SerotaMarcos C Schechter
Apr 2, 2021·Therapeutics and Clinical Risk Management·Oriana SimonettiAnnamaria Offidani
Apr 10, 2021·Surgical Infections·Christopher C CooperDaniel H Havlichek
Aug 11, 2019·International Journal of Antimicrobial Agents·Aurélien DinhUNKNOWN Dalbavancin French Study Group
May 8, 2021·Journal of Global Antimicrobial Resistance·Morgan MattUNKNOWN Dalbavancin French Study Group
May 28, 2021·Expert Opinion on Drug Safety·N Monteagudo-MartínezJ Jordán
Jun 3, 2021·Antibiotics·Luis Buzón-MartínJaime Lora-Tamayo
Jul 6, 2021·JAC-antimicrobial Resistance·Elizabeth HartRoss Thomson
Jul 15, 2021·The Annals of Pharmacotherapy·Elias B ChahineErenie H Guirguis
Jul 30, 2020·Thérapie·Benjamin ValentinEric Senneville
Dec 17, 2019·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Aaron HakimJudith Strymish
Dec 17, 2021·Infectious Diseases and Therapy·Guillaume BéraudMartin Blachier
Dec 21, 2021·Journal of Chemotherapy·Mohammad Said RamadanEmanuele Durante-Mangoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Antimicrobial Agents
Emilio BouzaDALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España)
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Kate Traynor
The New England Journal of Medicine
G Ralph CoreySOLO I Investigators
Enfermedades infecciosas y microbiología clínica
Dolors Rodríguez-Pardo
© 2022 Meta ULC. All rights reserved